October 01, 2025
Medical device manufacturer Medtronic PLC has escaped proposed investor class action claims it concealed issues affecting a certain insulin pump it makes, hurting investors after its trading prices fell when the company disclosed it had received a related warning letter from the U.S. Food and Drug Administration.
April 03, 2023
Medtronic wants out of a suit accusing it of hiding information that one of its insulin pumps was defective, ultimately leading to a stock drop, telling a Minnesota federal court that the proposed class of investors stitch together "an elaborate but ultimately untenable fraud narrative."
September 09, 2022
Medtronic was hit with a proposed class action Thursday by a group of pension funds alleging the medical device manufacturer hid that its insulin pumps were defective, causing its stock to tank when the U.S. Food and Drug Administration issued a warning letter.